Clinical Cardiology

View the latest content related to this topic

AHA 2018

AHA Puts Focus on the Impact of Violence on Cardiovascular Health

In a special session at the AHA’s annual meeting in Chicago, researchers argued that violence should be considered a CV risk factor.

Todd Neale

November 14, 2018

Slides

See all

AHA 2018

PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure

Presenter: Eric J Velazquez

November 12, 2018

Presentation

AHA 2018

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

Presenter: Sotirios Tsimikas

November 11, 2018

Presentation

CDM 2018

Are We Recognizing all of the Treatable Causes of Hypertension?

Presenter: J Brian Byrd

October 12, 2018

Presentation

CDM 2018

Comparing the Hypertension Guidelines: Resolving the Controversies

Presenter: Michael A.Weber

October 12, 2018

Presentation

CDM 2018

Cardiovascular Outcomes Trials (CVOT): Latest Results and Recommendations

Presenter: Dailey George

October 12, 2018

News

See all

News

WCC 2018

True Resistant Hypertension Is Prevalent Worldwide

By Todd Neale

December 07, 2018

News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

By Michael O'Riordan

December 06, 2018

News

NOACs Significantly Curb Risk of VTE in Cancer Patients

By L.A. McKeown

December 06, 2018

News

WCC 2018

WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai

By Todd Neale

December 05, 2018

News • Interventional

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

By Michael O'Riordan

December 04, 2018

CHIP: Practical Strategies for Troubleshooting Complex Cases

January 25

January 26, 2018

CTO 2019

February 28

March 01, 2019

AHA 2018

November 10

November 14, 2018

TCT 2018

September 21

September 25, 2018

Videos on This Topic

See all

Interview

TCT 2018: Dr. C. Michael Gibson talks with Dr. Philipp Lurz about RADIOSOUND-HTN

September 24, 2018

Advertisement

Clinical Cardiology

AHA Puts Focus on the Impact of Violence on Cardiovascular Health

Slides

PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

Are We Recognizing all of the Treatable Causes of Hypertension?

Comparing the Hypertension Guidelines: Resolving the Controversies

Cardiovascular Outcomes Trials (CVOT): Latest Results and Recommendations

News

True Resistant Hypertension Is Prevalent Worldwide

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

NOACs Significantly Curb Risk of VTE in Cancer Patients

WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

More on This Topic

Upcoming Conferences

CHIP: Practical Strategies for Troubleshooting Complex Cases

CTO 2019

Conference Coverage

AHA 2018

TCT 2018

Videos on This Topic

TCT 2018: Dr. C. Michael Gibson talks with Dr. Philipp Lurz about RADIOSOUND-HTN

Advertisement

Advertisement

Clinical Cardiology

Slides

News

More on This Topic

Upcoming Conferences

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content